JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albert, J. R.
Right arrow Articles by Weikel, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albert, J. R.
Right arrow Articles by Weikel, J. H., Jr.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Journal of Pharmacology And Experimental Therapeutics, Vol. 131, Issue 1, 85-90, 1961
Copyright © 1961 by American Society for Pharmacology and Experimental Therapeutics


ANTICONVULSANT AND TOXICOLOGIC PROPERTIES OF SOME BENZILIC AMIDES AND THE PHYSIOLOGICAL DISPOSITION OF THE N-ETHYL DERIVATIVE

James R. Albert 1, Gale C. Boxill 2, and John H. Weikel Jr. 1

1 Research Laboratories, Mead Johnson & Company, Evansville, Indiana
2 Department of Pharmacology, Warner-Lambert Research Institute, Morris Plains, New Jersey

The aniticonvulsant properties and toxicities of benzilic amide and a series of its N-substituted derivatives were studied. The parent compound and its methyl, ethyl and isopropyl analogues had marked activity in protecting against maximal electroshock seizures. These agents, with the exception of N-methyl benzilic amide, also demonstrated similar activity against pentylenetetrazol (Metrazol) convulsions. Unsubstituted benzilic amide was the most potent against both types of seizures, while the N-ethyl and N-isopropyl derivatives, due to their lower neurotoxicities, had optimal protective indices w-hen measured against both convulsions.

With the aid of an anualytical method developed for the estimation of N-ethyl benzilic amide, its physiological disposition was investigated in rats and mice. Approximately one-third of an oral dose could be accounted for in the urine, but the nature of the urinary excretory products was incompletely known. One of these products of metabolism was demonstrated to be benzilic amide. The role of benzilic amide in the pharmacodynamic activity of N-ethyl benzilic amide and the importance of N-dealkylation in the production of tolerance to the action of the amide were discussed.

Submitted on June 13, 1960







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1961 by the American Society for Pharmacology and Experimental Therapeutics.